发表研究结果有使用 ab108340?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab108340 被引用在 1 文献中.

  • Crawford LJ  et al. Synergistic effects of proteasome inhibitor carfilzomib in combination with tyrosine kinase inhibitors in imatinib-sensitive and -resistant chronic myeloid leukemia models. Oncogenesis 3:e90 (2014). WB ; Human . PubMed: 24590311

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"